Vanguard Global Advisers
REPL icon

Vanguard Global Advisers’s Replimune Group REPL Stock Holding History

Vanguard Global Advisers’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$324K Hold
29,299
– – ﹤0.01% 2296
2026
Q1 		$224K Buy
+29,299
New +$224K ﹤0.01% 2384

Other funds holding REPL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
RCI
Ridgeback Capital Investments Miami Beach, Florida $80.9M AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

Vanguard Global Advisers's REPL Position: Q2 2026 in Review

Vanguard Global Advisers held its Replimune Group (REPL) position steady in Q2 2026 at 29,299 shares worth $324K. The position accounts for ﹤0.01% of the portfolio, ranked #2296.

Vanguard Global Advisers first reported a position in REPL in Q1 2026 and has held it in 2 quarters since. 198 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

  • Vanguard Global Advisers held 29,299 shares of Replimune Group worth $324K as of Q2 2026.
  • Vanguard Global Advisers left its Replimune Group share count unchanged in Q2 2026.
  • Replimune Group made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #2296 holding.
  • Vanguard Global Advisers first reported a position in Replimune Group in Q1 2026 and has held it in 2 quarters since.
  • 198 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.